Difficulty: Medium
Average Score: 66%
Practice
Select the anticholinesterase drug that is being used to afford symptomatic improvement in Alzheimer's disease
Correct answer
B
Rationale
In the context of Alzheimer's disease, the correct answer is B) Tacrine. Tacrine is a centrally acting anticholinesterase drug that is used to improve cognitive function and alleviate symptoms in patients with Alzheimer's disease. This drug works by inhibiting the breakdown of acetylcholine, a neurotransmitter involved in memory and learning processes that are depleted in Alzheimer's patients.
Option A) Echothiophate is primarily used to treat glaucoma by lowering intraocular pressure and has no direct application in Alzheimer's disease.
Option C) Demecarium is a long-acting cholinesterase inhibitor used to treat glaucoma and has no established role in managing Alzheimer's disease symptoms.
Option D) Ambenonium is a reversible cholinesterase inhibitor primarily used to treat myasthenia gravis, a neuromuscular disorder, and is not indicated for Alzheimer's disease.
Understanding the mechanism of action and appropriate clinical applications of anticholinesterase drugs is essential for nursing and medical professionals caring for patients with Alzheimer's disease. By selecting the correct medication, healthcare providers can help improve the quality of life and cognitive function in individuals with this progressive neurological condition.
Option A) Echothiophate is primarily used to treat glaucoma by lowering intraocular pressure and has no direct application in Alzheimer's disease.
Option C) Demecarium is a long-acting cholinesterase inhibitor used to treat glaucoma and has no established role in managing Alzheimer's disease symptoms.
Option D) Ambenonium is a reversible cholinesterase inhibitor primarily used to treat myasthenia gravis, a neuromuscular disorder, and is not indicated for Alzheimer's disease.
Understanding the mechanism of action and appropriate clinical applications of anticholinesterase drugs is essential for nursing and medical professionals caring for patients with Alzheimer's disease. By selecting the correct medication, healthcare providers can help improve the quality of life and cognitive function in individuals with this progressive neurological condition.